6 posts • Page 1 of 1
There are 3 different depots in the pipeline by Indivior, Braeburn, and BDSI. Indivior will be first to market. BDSI likely will have a more convenient delivery system but may be last to market. The biggest barrier I see (besides cost and patient willingness) is what hassle will be needed to keep a controlled depot substance on site in an outpatient environment.
Who is online
Users browsing this forum: No registered users and 1 guest